Join our distinguished special panel to explore the critical intersection of medical device innovation and regulatory guidance. The panel will unpack the complex path from scientific discovery to market-ready medical innovation. We'll explore the strategic, technical and regulatory considerations that transform promising research into technologies that can improve patient care.
This session is ideal for anyone interested in medical devices and understanding the journey from idea to real-world healthcare applications.
Our expert panelists will share their practical insights on:
- Navigating FDA approval processes
- Balancing innovation with regulatory compliance
- Strategies for successful device development
- Emerging challenges in medical device development
Whether you're considering a new idea, commercialization, or actively developing medical device solutions, this panel offers valuable perspectives on turning promising research into market-ready medical devices.
Panelists:
- Mark Melkerson, former FDA Deputy Director, Office of Health Technology / CDRH / ODE and current MNM Consulting
- Thomas Roueche, President and CEO, Fesarius Therapeutics
- Jason Spector, M.D., Chief of the Division of Plastic and Reconstructive Surgery at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, Co-Founder of Fesarius Therapeutics